Mundipharma Pharmaceuticals Ltd
- C08 - Bloqueantes del canal de calcio
- ADIZEM-SR prolonged-release capsule, hard 120 mg
- ADIZEM-SR prolonged-release capsule, hard 180 mg
- ADIZEM-SR prolonged-release capsule, hard 90 mg
- ADIZEM-XL prolonged-release capsule, hard 120 mg
- ADIZEM-XL prolonged-release capsule, hard 180 mg
- ADIZEM-XL prolonged-release capsule, hard 240 mg
- ADIZEM-XL prolonged-release capsule, hard 300 mg
- N02 - Analgésicos
- BUTRANS transdermal patch 10 µg/h
- BUTRANS transdermal patch 15 µg/h
- BUTRANS transdermal patch 20 µg/h
- BUTRANS transdermal patch 5 µg/h
- MST CONTINUS prolonged-release tablet 10 mg
- MST CONTINUS prolonged-release tablet 100 mg
- MST CONTINUS prolonged-release tablet 15 mg
- MST CONTINUS prolonged-release tablet 30 mg
- MST CONTINUS prolonged-release tablet 5 mg
- MST CONTINUS prolonged-release tablet 60 mg
- OXYCONTIN prolonged-release tablet 10 mg
- OXYCONTIN prolonged-release tablet 20 mg
- OXYCONTIN prolonged-release tablet 40 mg
- OXYCONTIN prolonged-release tablet 5 mg
- OXYCONTIN prolonged-release tablet 80 mg
- OXYNORM capsule, hard 10 mg
- OXYNORM capsule, hard 20 mg
- OXYNORM capsule, hard 5 mg
- OXYNORM CONCENTRATE oral drops, solution 10 mg/ml
- OXYNORM DISPERSA orodispersible tablet 10 mg
- OXYNORM DISPERSA orodispersible tablet 20 mg
- OXYNORM DISPERSA orodispersible tablet 5 mg
- OXYNORM LIQUID oral solution 1 mg/ml
- OXYNORM solution for injection 10 mg/ml
- OXYNORM solution for injection 50 mg/ml
- PALLADONE capsule, hard 1.3 mg
- PALLADONE capsule, hard 2.6 mg
- PALLADONE SR prolonged-release capsule, hard 16 mg
- PALLADONE SR prolonged-release capsule, hard 2 mg
- PALLADONE SR prolonged-release capsule, hard 24 mg
- PALLADONE SR prolonged-release capsule, hard 4 mg
- PALLADONE SR prolonged-release capsule, hard 8 mg
- SEVREDOL film-coated tablet 20 mg
- SEVREDOL film-coated tablet 50 mg
- TARGIN prolonged-release tablet 10 mg+5 mg
- TARGIN prolonged-release tablet 15 mg+7.5 mg
- TARGIN prolonged-release tablet 20 mg+10 mg
- TARGIN prolonged-release tablet 30 mg+15 mg
- TARGIN prolonged-release tablet 40 mg+20 mg
- TARGIN prolonged-release tablet 5 mg+2.5 mg
- TARGIN prolonged-release tablet 60 mg+30 mg
- TARGIN prolonged-release tablet 80 mg+40 mg
- R03 - Agentes contra padecimientos obstructivos de las vías respiratorias
- FLUTIFORM K-HALER pressurised inhalation, suspension 5 µg/dose+125 µg/dose
- FLUTIFORM K-HALER pressurised inhalation, suspension 5 µg/dose+50 µg/dose
- FLUTIFORM pressurised inhalation, suspension 10 µg/dose+250 µg/dose
- FLUTIFORM pressurised inhalation, suspension 5 µg/dose+125 µg/dose
- FLUTIFORM pressurised inhalation, suspension 5 µg/dose+50 µg/dose
- PHYLLOCONTIN CONTINUS prolonged-release tablet 225 mg
- UNIPHYLLIN CONTINUS prolonged-release tablet 200 mg
- UNIPHYLLIN CONTINUS prolonged-release tablet 300 mg
- UNIPHYLLIN CONTINUS prolonged-release tablet 400 mg